Join us   Log in  


Pages: 1064-1072
Print Article   Download XML  Download PDF

Prevalence, Awareness, Treatment and Socioeconomic and Demographic Determinants of Hypertension Among Adults in Salé-Morocco in 2021: a Cross-Sectional Survey

Author: Abdelghani Asraoui, Chems Eddouha Khassouani, Abdelmajid Soulaymani

Category: JMSR Cardiovascular Disease


Background: Hypertension (HTN) is a major risk factor for cardiovascular disease. The purpose of this study was to assess the prevalence, awareness, treatment, and socio-economic and demographic risk factors of HTN in the adult population of Salé, Morocco. Methods: A cross-sectional study was conducted, in February 2021, using a stratified probabilistic sampling plan with two stages. Based on a questionnaire, we gathered information on hypertension and some socio-economic and demographic variables. Results: The overall prevalence of HTN among adults (18 years and older, N = 1308) in Salé was 10.2% (n = 133, 95% CI: 8.6%, 11.9%). This prevalence was equal to that recorded nationally in 2018; 8.2% of men and 12.0% of women were hypertensive. HTN prevalence increased with age in both sexes. Among hypertensive people, 96.2% (n = 128, 95% CI: 92.0%, 98.6%) were aware of their disease, and 73.9% (n = 98, 95% CI: 65.7%, 80.6%) were following regular treatment for raised blood pressure. It was also found that gender, age, educational level, marital status, occupation, smoking status, being either head of the household or not, and diabetes status were significantly associated with hypertension. Conclusion: Salé city is dealing with serious and multiple health problems (stroke, myocardial infarction, renal failure, arteriopathy of the lower limbs, and risk of fetal mortality…) as well as costly therapy. Our research suggests that decision-makers and healthcare management in Salé should pay more attention to developing adequate hypertension preventive and treatment strategies.

Keywords: Prevalence, Hypertension, Epidemiology, Chronic disease, Risk factors, Sale, Morocco


  1. World Health Organization. Non communicable diseases country profiles 2018. Geneva. 2018; p.7. [Accessed on 25/06/2021]
  2. World Health Organization. World health statistics 2020: monitoring health for the SDGs, sustainable development goals. Geneva. 2020; p. 14. [Accessed on 16/09/2021]
  3. Ministry of Health (Morocco). National Survey on Common Risk Factors for Non-Communicable Diseases, STEPS, 2017-2018. Rabat. 2019; p. 12. [Accessed on 22/09/2021]
  4. Ministry of Health (Morocco). National Survey on Population and Family Health (ESPFH-2018). Rabat. 2019. [Accessed on 22/09/2021]
  5. Statistics Canada. Survey Methods and Practices. Ottawa. 2010. p.151-175. Accessed on 11/11/2021
  6. Ministry of Health (Morocco). Projections des populations cibles des programmes de santé. Rabat. 2017. accessed on 22/09/2021
  7. Eng J. Sample size estimation: how many individuals should be studied?. Radiology 2003; 227(2): 309-313.
  8. Deming WE. Quelques méthodes de sondage. Revue de statistique appliquée. 1964 ; 12(4): 11-55. accessed on 22/09/2021
  9. Gee ME, Campbell N, Sarrafzadegan N, Jafar T, Khalsa TK, Mangat B, Poulter N, Prabhakaran D, Sonkodi S, Whelton PK, Woodward M, & Zhang XH. Standards for the uniform reporting of hypertension in adults using population survey data: recommendations from the World Hypertension League Expert Committee. The Journal of Clinical Hypertension. 2014; 16(11): 773-781.
  10. Bloomgarden ZT. Third Annual World Congress on the insulin resistance syndrome: associated conditions. Diabetes Care. 2006; 29(2): 2165-2174.
  11. Seravalle G & Grassi G. Obesity and hypertension. Pharmacological research. 2017;122: 1-7.
  12. Eghbali M, Khosravi A, & Feizi A. Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran. Epidemiology and health. 2018; 40: e2018020.
  13. Nikooyeh B, Abdollahi Z, Salehi F, Nourisaeidlou S, Hajifaraji M, Zahedirad M, Shariatzadeh N, Kalayi A, Balderlou FB, Salmasi JG, Entezarmahdi R, Ghorbannezhad Z, Lotfollahi N, Maleki M, & Neyestani TR. Prevalence of obesity and overweight and its associated factors in urban adults from West Azerbaijan, Iran: the National Food and Nutritional Surveillance Program (NFNSP). Nutrition and Food Sciences Research. 2016; 3(2): 21-26.
  14. Garawi F, Devries K, Thorogood N, & Uauy R. Global differences between women and men in the prevalence of obesity: is there an association with gender inequality? European journal of clinical nutrition. 2014; 68(10): 1101-1106.
  15. Dosoo DK, Nyame S, Enuameh Y, Ayetey H, Danwonno H, Twumasi M, Tabiri C, Gyaase S, Lip GYH, Owusu-Agyei S, & Asante KP. Prevalence of hypertension in the middle belt of Ghana: a community-based screening study. International journal of hypertension. 2019; 2019.
  16. Haghdoost A , Sadeghirad B & Rezazadehkermani M. Epidemiology and heterogeneity of hypertension in Iran: a systematic review. Arch Iran Med. 2008;11: 444-452.
  17. Kishore J, Gupta N, Kohli C, & Kumar N. Prevalence of hypertension and determination of its risk factors in rural Delhi. International journal of hypertension. 2016; 2016.
  18. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, & Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. Jama. 2002; 287(8): 1003-1010. https://doi:10.1001/jama.287.8.1003
  19. Ziyyat A, Ramdani N, Bouanani NEH, Vanderpas J, Hassani B, Boutayeb A, Aziz M, Mekhfi H, Bnouham M & Legssyer A. Epidemiology of hypertension and its relationship with type 2 diabetes and obesity in eastern Morocco. Springerplus. 2014; 3(1): 1-7.
  20. Tazi MA, Abir-Khalil S, Chaouki N, Cherqaoui S, Lahmouz F, Sraïri JE, & Mahjour J. Prevalence of the main cardiovascular risk factors in Morocco: results of a National Survey, 2000. Journal of hypertension. 2003; 21(5): 897-903.
  21. Hoeymans N, Smit HA, Verkleij H, & Kromhout D. Cardiovascular risk factors in relation to educational level in 36 000 men and women in The Netherlands. European heart journal. 1996; 17(4): 518-525.
  22. Sleight P. Smoking and hypertension. Clinical and experimental hypertension. 1993; 15(6): 1181-1192.
  23. Thorolfsdottir RB, Aspelund T, Capewell S, Critchley J, Gudnason V, & Andersen K. Population assessment of future trajectories in coronary heart disease mortality. PloS one. 2014; 9(1): e85800.
  24. Schutta MH. Diabetes and hypertension: epidemiology of the relationship and pathophysiology of factors associated with these comorbid conditions. Journal of the cardiometabolic syndrome. 2007; 2(2): 124-130.
  25. Ucan O & Ovayolu N. Relationship between diabetes mellitus, hypertension and obesity, and health?related quality of life in Gaziantep, a central south?eastern city in Turkey. Journal of clinical nursing. 2010; 19(17-18): 2511-2519.
  26. Paul B, Sapra B, Maheshwari S, & Goyal RK. Role of losartan therapy in the management of diabetic hypertension. The Journal of the Association of Physicians of India. 2000; 48(5): 514-518.
  27. Mulè G, Calcaterra I, Nardi E, Cerasola G, & Cottone S. Metabolic syndrome in hypertensive patients: an unholy alliance. World journal of cardiology. 2014; 6 (9): 890.
  28. Modesti PA, Bamoshmoosh M, Rapi S, Massetti L, Al-Hidabi D, & Al Goshae H. Epidemiology of hypertension in Yemen: effects of urbanization and geographical area. Hypertension research. 2013; 36(8): 711-717.
  29. Lamelas P, Diaz R, Orlandini A, Avezum A, Oliveira G, Mattos A, Lanasd F, Serond P, Oliverosd MJ, Lopez-Jaramilloe P, Oteroe J, Camachoe P, Mirandaf J, Bernabe-Ortizf A, Malagaf G, Irazolag V, Gutierrezg L, Rubinsteing A, Castellanab N, Rangarajana S, & Yusufa S. Prevalence, awareness, treatment and control of hypertension in rural and urban communities in Latin American countries. Journal of hypertension. 2019; 37(9): 1813-1821. https://doi: 10.1097/HJH.0000000000002108
  30. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, & He J. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016; 134(6): 441-450.
  31. Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, Bo J, Lou Q, Lu F, Liu T, Yu L, Zhang S, Mony P, Swaminathan S, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear S, Anand S, Wielgosz A et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries.New England Journal of Medicine. 2014; 371(9): 818-827.